-
Mashup Score: 0All Things Considered for August 1, 2023 - 10 month(s) ago
Hear the All Things Considered program for August 1, 2023
Source: www.npr.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3DNA sequencing can lead to longer, better lives for cancer patients. But why do so few get it? - 12 month(s) ago
Despite guidelines and the common use of genetic sequencing for cancer patients at major medical centers, experts say many patients are missing out.
Source: USA TODAYCategories: Latest Headlines, Oncologists1Tweet-
DNA sequencing improves cancer treatment but remains underused. Why? https://t.co/xZsM3xt9Jr
-
-
Mashup Score: 0Germline Genetic Testing After Cancer Diagnosis - 12 month(s) ago
This observational study describes the prevalence of germline genetic testing in California and Georgia between 2013 and 2019 among patients diagnosed with cancer.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Germline Genetic Testing After Cancer Diagnosis | Breast Cancer | JAMA | JAMA Network https://t.co/nWSgwFz73B
-
-
Mashup Score: 4Antibiotics after breast cancer linked to poorer survival, Stanford Medicine-led study finds - 1 year(s) ago
Triple-negative breast cancer patients who used antibiotics within three years of diagnosis have an increased risk of death, according to a study. The gut microbiome is a likely link.
Source: News CenterCategories: Hem/Oncs, Latest HeadlinesTweet-
A press release on our recent study: https://t.co/sUoVqCmglj
-
-
Mashup Score: 0Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer - 1 year(s) ago
Antimicrobial exposure during curative-intent treatment of triple-negative breast cancer (TNBC) may lead to gut microbiome dysbiosis, decreased circulating and tumor-infiltrating lymphocytes, and inferior outcomes. Here, we investigate the association of antimicrobial exposure and peripheral lymphocyte count during TNBC treatment with survival, using integrated electronic medical record and…
Source: www.nature.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Excited to see our paper on antibiotics and triple-negative breast cancer mortality just published in Nature Communications: https://t.co/PyWJmMPO2Z.
-
-
Mashup Score: 0Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer - 1 year(s) ago
Read the paper: https://rdcu.be/c9Nkz
Categories: Hem/Oncs, Latest HeadlinesTweet-
And here is our blog post: https://t.co/UN8pPy3vlk.
-
-
Mashup Score: 0
This case-control study investigates the quality of breast cancer treatment and recurrence outcomes for patients from sex and gender minority groups compared with cisgender heterosexual patients.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Breast Cancer Diagnosis, Treatment, and Outcomes of Patients From SGM Groups https://t.co/2CFuB6MKle via @JAMAOnc part of @JAMANetwork
-
-
Mashup Score: 2
We are interested in the opinions of individuals who have been diagnosed with early-stage (stage 0-III) breast cancer. We would like to ask you questions about your diagnosis to determine if you might be eligible to be invited to take a short survey. The purpose of the survey is to help us provide a better experience for patients who choose to take part in a breast cancer clinical trial.
Source: stanforduniversity.qualtrics.comCategories: Hem/Oncs, Latest HeadlinesTweet-
If you have ever been diagnosed with stage 0-3 breast cancer, please consider helping Stanford breast cancer researchers understand your perspectives on a new kind of clinical trial by filling out this short survey: https://t.co/ijEY5AAp73 #bcsm (retweets appreciated!)
-
-
Mashup Score: 3
Stay logged in for 4 weeks(DO NOT check on a shared computer)
Source: lane.stanford.eduCategories: Hem/Oncs, Latest HeadlinesTweet-
Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis | Breast Cancer | JAMA Oncology | JAMA Network https://t.co/PayjFf6sJ6
-
-
Mashup Score: 0Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility Genes - 2 year(s) ago
PURPOSE Family cancer history is an important component of genetic testing guidelines that estimate which patients with breast cancer are most likely to carry a germline pathogenic variant (PV). However, we do not know whether more extensive family history is differentially associated with PVs in specific genes. METHODS All women diagnosed with breast cancer in 2013-2017 and reported to statewide…
Source: JCO Precision OncologyCategories: Hem/Oncs, Latest HeadlinesTweet-
Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility Genes https://t.co/UL3VAcjgIb
-
All Things Considered : NPR https://t.co/o55rt9ab2Z